on March 16, 2006
Published online before print March 16, 2006, doi: 10.1161/01.ATV.0000217610.58032.b7
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on December 1, 2005
Accepted on March 2, 2006
Early Lymph Vessel Development From Embryonic Stem Cells
Johan Kreuger *;
From the Department of Genetics and Pathology (J.K., I.N., L.C.-W.) Uppsala University, Sweden; the Department of Pathology (D.K.), University of Vienna Medical School, Austria; Molecular/Cancer Biology Laboratory and Ludwig Institute for Cancer Research (T.P., K.A.), Helsinki University Central Hospital, Finland.
* To whom correspondence should be addressed. E-mail: johan.kreuger{at}genpat.uu.se.
Objective--The purpose of this study was to establish a model system for lymph vessel development based on directed differentiation of murine embryonic stem cells.
Methods and Results--Stem cells were aggregated to form embryoid bodies, and subsequently cultured in 3-dimensional collagen matrix for up to 18 days. Treatment with vascular endothelial growth factor (VEGF)-C and VEGF-A individually enhanced formation of lymphatic vessel structures, although combined treatment with VEGF-C and VEGF-A was most potent and gave rise to a network of LYVE-1, podoplanin, Prox1, and VEGF receptor-3 positive lymphatic vessel structures running parallel to and apparently emanating from, capillaries. In contrast, fibroblast growth factor-2, hepatocyte growth factor, or hypoxia had little or no effect on the development of the early lymphatics. Further, cells of hematopoietic origin were shown to express lymphatic markers. In summary, different subpopulations of lymphatic endothelial cells were identified on the basis of differential expression of several lymphatic and blood vessel markers, indicating vascular heterogeneity.
Conclusions--We conclude that the present model closely mimics the early steps of lymph vessel development in mouse embryos.
Key words: embryoid body • lymphangiogenesis • LYVE-1 • Prox1 • VEGF-C • VEGF receptor-3
This article has been cited by other articles:
 |
|
 |
|
  M. Oka, C. Iwata, H. I. Suzuki, K. Kiyono, Y. Morishita, T. Watabe, A. Komuro, M. R. Kano, and K. Miyazono Inhibition of endogenous TGF-{beta} signaling enhances lymphangiogenesis Blood, May 1, 2008; 111(9): 4571 - 4579. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Kilic, L. Oliveira-Ferrer, S. Neshat-Vahid, S. Irmak, K. Obst-Pernberg, J.-H. Wurmbach, S. Loges, E. Kilic, J. Weil, H. Lauke, et al. Lymphatic reprogramming of microvascular endothelial cells by CEA-related cell adhesion molecule-1 via interaction with VEGFR-3 and Prox1 Blood, December 15, 2007; 110(13): 4223 - 4233. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Jakobsson, J. Kreuger, and L. Claesson-Welsh Building blood vessels--stem cell models in vascular biology J. Cell Biol., June 21, 2007; 177(5): 751 - 755. [Abstract] [Full Text] [PDF]
|
|